CMS Accepts Medtronic’s Request To Reconsider MRI/Pacemaker Policy
This article was originally published in The Gray Sheet
Executive Summary
CMS has accepted Medtronic’s request to reconsider its recent final coverage decision preventing routine Medicare reimbursement for magnetic resonance imaging scans in patients with implanted pacemakers and defibrillators.
You may also be interested in...
Industry Asks CMS Not To Tread On FDA's Medtech Safety Authority
CMS should leave questions regarding medtech safety to FDA rather than re-examine them in coverage with evidence development studies, according to physicians and industry stakeholders.
Industry Asks CMS Not To Tread On FDA's Medtech Safety Authority
CMS should leave questions regarding medtech safety to FDA rather than re-examine them in coverage with evidence development studies, according to physicians and industry stakeholders.
Study Resumes Site Recruitment To Test MRIs On Pacemaker/ICD Patients
A national study seeking to determine the effect of MRI scans on patients with pacemakers or implantable defibrillators has resumed site recruitment, following a recent CMS decision to allow reimbursement in agency-sanctioned clinical trials.